Latest / Ageless Future / Exploring the Future of Regenerative Medicine: Research Perspectives on MUSE Cells and Longevity
Transcript
- 0:00Speaker 1: Researchers are.
- 0:01Speaker 2: They're describing these muse cells as one of the most
- 0:05Speaker 2: intriguing discoveries in regenerative medicine over the past decade. Rather
- 0:09Speaker 2: than forcing the body to repair itself, these scientists are
- 0:13Speaker 2: interested in understanding how these cells may work alongside the
- 0:17Speaker 2: body's natural recovery systems. I remember growing up it's like,
- 0:21Speaker 2: if you can never get back brain cells, you know,
- 0:24Speaker 2: don't hold your breath too long, or don't do this,
- 0:27Speaker 2: or don't get traumatic brain intrigues. And we've discovered that's
- 0:30Speaker 2: not necessarily the case.
- 0:31Speaker 1: Your brain can regenerate, but it's very difficult.
- 0:34Speaker 2: It's very limited natural repair capacity compared to other tissues
- 0:39Speaker 2: in the body. The sky's the limits. It's when we
- 0:43Speaker 2: kind of sit back and let a disease or a
- 0:45Speaker 2: diagnosis put a label on us and use that as
- 0:49Speaker 2: you know what, as an identity, and those things are
- 0:54Speaker 2: what we've seen historically really create a downward spiral. We
- 0:58Speaker 2: have the data we're testing over and over. It's almost
- 1:02Speaker 2: like that the future of personalized regenitative medicine is here
- 1:06Speaker 2: right now at Ageless Future.
- 1:22Speaker 1: Welcome everybody to the.
- 1:24Speaker 2: Ageless Future podcast. This is your host today Kate Archibald,
- 1:29Speaker 2: We're gonna continue on the same same pathway that we've
- 1:35Speaker 2: been working on with some of the regenerative medicines, stem cells,
- 1:40Speaker 2: specifically MEW cells, and some of the most latest and
- 1:45Speaker 2: greatest research around new cells. So I'm excited to dive
- 1:51Speaker 2: in today.
- 1:52Speaker 1: Think about this.
- 1:53Speaker 2: We have this next frontier in regenerative medicine. Regenera medicine
- 1:58Speaker 2: has been around for a few years. It's you know,
- 2:01Speaker 2: it's still relatively new, but there's just more and more
- 2:07Speaker 2: coming out with regenerative medicine.
- 2:10Speaker 1: And you know.
- 2:11Speaker 2: We're seeing why researchers are watching U cells so closely,
- 2:17Speaker 2: just a lot of really really cool dynamics there.
- 2:22Speaker 1: And so.
- 2:24Speaker 2: What what makes these mu cells different and and how
- 2:30Speaker 2: they're they're so dynamic is you know, and and a
- 2:36Speaker 2: lot of different cell therapies they focus on delivering cells
- 2:41Speaker 2: into the body and just hoping they'll survive. But what
- 2:46Speaker 2: what we're seeing U cells appear to be different where
- 2:52Speaker 2: you know, they can They've been observed a lot of
- 2:56Speaker 2: different characteristics that make it you know, seems like the
- 3:01Speaker 2: ability for them to outstand a lot of the environment
- 3:07Speaker 2: inside the human body. They can withstand a lot more
- 3:10Speaker 2: and potentially have a lot more therapeutic effects. So they've observed,
- 3:18Speaker 2: you know, they naturally migrate towards injured tissue, and we've
- 3:23Speaker 2: seen this with with just traditional umbilical cord tissue stem cells.
- 3:30Speaker 2: But what we're seeing with muse cells is that concentration
- 3:35Speaker 2: is a lot more consistent, and so you're getting you know,
- 3:39Speaker 2: with with like what those mus cells in on if
- 3:42Speaker 2: you take just a traditional vial of stem cells, is
- 3:46Speaker 2: you know, you'll have mus cells in there. And those
- 3:49Speaker 2: are the most potent and powerful, most robust cells discovered
- 3:57Speaker 2: in Japan, as we've we've talked previously, and they're able
- 4:01Speaker 2: to handle a lot more stress and they're more resilient
- 4:05Speaker 2: than some of those some of the other cells or
- 4:09Speaker 2: stem cells in there. And so now we've we've worked
- 4:13Speaker 2: with a lab to kind of condense those and just
- 4:17Speaker 2: focus on the MU cells rather than you know, the
- 4:20Speaker 2: whole profile, which you know, the whole profile very very
- 4:25Speaker 2: effective with protein CETO kinds. The amino acid change that
- 4:30Speaker 2: you get from that of bilical cord birth tissue, even
- 4:33Speaker 2: without the live stem cells, can be just therapeutic in
- 4:37Speaker 2: and of itself. But now you're getting that along with
- 4:42Speaker 2: just concentrated muse cells, and you know, theoretically could be
- 4:48Speaker 2: completely game changing from a clinical application, we're starting to
- 4:52Speaker 2: see that where you know, non responders are getting responses
- 4:56Speaker 2: from these muse cells versus you know, what they've done
- 5:01Speaker 2: in the past. But I'm gonna talk of getting off
- 5:03Speaker 2: on a tangent here. We're going to focus on this
- 5:05Speaker 2: kind of researchers what what they're looking at. They're they're
- 5:09Speaker 2: studying this kind of natural repair oriented behavior, the unique
- 5:14Speaker 2: biology like they're they're starting to get a lot more
- 5:19Speaker 2: global interest.
- 5:22Speaker 1: You know.
- 5:22Speaker 2: They they appear to be capable of surviving very stressful environments,
- 5:27Speaker 2: they can integrate into different tissue environments, they seem to
- 5:32Speaker 2: interact with the immune system differently than other cell types,
- 5:37Speaker 2: and so, you know, because of these these traits, researchers
- 5:41Speaker 2: are they're they're describing these mute cells as one of
- 5:46Speaker 2: the most intriguing discoveries in regenerative medicine over the past decade.
- 5:50Speaker 2: Uh And so, rather than forcing the body to repair itself,
- 5:54Speaker 2: these scientists are interested in understanding how these cells may
- 5:59Speaker 2: work along the body's natural recovery systems. And that's what
- 6:03Speaker 2: I think is really fascinating if you look at you know,
- 6:08Speaker 2: the these the research behind us is, you know, really
- 6:13Speaker 2: you're having all these scientists and researchers really dive in
- 6:17Speaker 2: because the possibilities seem, you know, very very promising. And
- 6:23Speaker 2: you know, we've started, you know, taking taking this on
- 6:27Speaker 2: from a clinical standpoint on more of a much much
- 6:31Speaker 2: smaller scale, but seeing seeing phenomenal outcomes there as well.
- 6:38Speaker 2: But let's let's talk about the potential advantage on the
- 6:41Speaker 2: immune immune tolerance side of things. So, you know, one
- 6:47Speaker 2: one of the major challenges in regenitive medicine historically has
- 6:51Speaker 2: been this thought process of immune rejection. So you know,
- 6:57Speaker 2: if especially if you're you're you know, infusing or injecting
- 7:03Speaker 2: certain cell types, there's always risk of immune rejection. Where
- 7:09Speaker 2: we haven't necessarily experienced that with the specific stem cells
- 7:13Speaker 2: in you know, with umbilical cord tissue where they haven't
- 7:18Speaker 2: been been shown a specific lineage yet. But when you
- 7:23Speaker 2: get into more manipulated stem cells and you know, specific
- 7:30Speaker 2: cells for particular line cell lineages, so if they've been
- 7:36Speaker 2: kind of transformed to be more chondrocites or heart cells
- 7:40Speaker 2: or brain cells things like that, it's where there's there's
- 7:44Speaker 2: little very much higher risk of immune rejection where you know,
- 7:50Speaker 2: if you look at mute cells, they appear to be
- 7:53Speaker 2: you know, unusually well tolerated in these research settings as
- 7:56Speaker 2: far as being able to be dynamic and not have
- 8:00Speaker 2: that same risk factor of immune rejection. And they're dynamic
- 8:04Speaker 2: enough where they're able to follow those lineages, so you know,
- 8:09Speaker 2: really may simplify that kind of future potential therapeutic applications.
- 8:18Speaker 2: So another thing that researchers are heavily investigating and researching
- 8:26Speaker 2: is IV delivery. So you know, and I think that
- 8:32Speaker 2: you know, if you think about innravenous delivery or some
- 8:36Speaker 2: form of systemic effect is always you know, I've I've
- 8:42Speaker 2: talked to a lot of clients and patients over the
- 8:45Speaker 2: years about different stem cell applications and things, and I
- 8:49Speaker 2: think everyone asks, you know, can I just get an
- 8:53Speaker 2: IV and we'll let, you know, fix my back pain
- 8:55Speaker 2: and fix every problem in my body, And it's typically
- 8:59Speaker 2: not the case.
- 9:01Speaker 1: What what these ivs are.
- 9:03Speaker 2: Doing is they're more focused on the internal organs and
- 9:08Speaker 2: system in the body versus you know, you have direct
- 9:11Speaker 2: injections for or like if you have isolated injuries. We
- 9:16Speaker 2: want to get a higher concentration into that area. But
- 9:19Speaker 2: what's so fascinating is we we've seen this natural homing behavior.
- 9:28Speaker 2: And you know, and I wish I had the diagram here,
- 9:31Speaker 2: I've I've showed it in the past, but there's a
- 9:35Speaker 2: study done where they radio tagged stem cells in this
- 9:39Speaker 2: ivy administered it through the left hand, you know, just
- 9:46Speaker 2: through a vein there pushed stem cells. And this person
- 9:52Speaker 2: had right hand arthritis and a few other things, and
- 9:57Speaker 2: so they took it a scan immediately after the procedure
- 10:02Speaker 2: and you could actually see where the stem cells had
- 10:04Speaker 2: migrated based on those radio tags, and you saw a
- 10:10Speaker 2: clump in that right hand where there was arthritis. There
- 10:14Speaker 2: was a lot in the internal organs, lungs, liver, and
- 10:20Speaker 2: a little in the thyroid. And what was interesting is
- 10:23Speaker 2: this person also had some diabetes and thyroid issues, and
- 10:31Speaker 2: so you know, I saw it in the pancreas, liver, thyroid,
- 10:35Speaker 2: some of the lungs, and then right hand arthritis. Took
- 10:39Speaker 2: another scan ninety days later and you could still see
- 10:42Speaker 2: the clump in the right hand and there was still
- 10:46Speaker 2: remnants of those cells in those particular areas.
- 10:50Speaker 1: So showing that they home in on.
- 10:54Speaker 2: Areas of you know, whether it's damage tissue or immune
- 10:59Speaker 2: compromise to issue, and you know, really really interesting on
- 11:06Speaker 2: the homing side if you look at it from you
- 11:08Speaker 2: cells in the brain, a lot of interesting neurological uh
- 11:18Speaker 2: impacts there. So if you think about it, the brain,
- 11:22Speaker 2: and historically, like I remember growing up, it was like
- 11:24Speaker 2: if you know you can never get back brain cells,
- 11:28Speaker 2: you know, don't don't hold your breath too long, or
- 11:30Speaker 2: don't do this, don't do that, or don't get traumatic
- 11:34Speaker 2: brain injuries. And we've discovered that's not necessarily the case.
- 11:37Speaker 2: Your brain can regenerate, but it's very difficult. It's very
- 11:42Speaker 2: limited natural repair capacity compared to other tissues in the body.
- 11:47Speaker 2: And so the brain's always a very exciting place of
- 11:53Speaker 2: research just because of the possibilities like if if we
- 11:56Speaker 2: can keep our brains online and cognitive of and thinking
- 12:00Speaker 2: and processing remembering things appropriately. You know that in our mind, Like,
- 12:08Speaker 2: the brain is one of the biggest pillars when it
- 12:11Speaker 2: comes to longevity, because if you lose your cognitive abilities,
- 12:16Speaker 2: it doesn't matter how healthy the rest of your body is.
- 12:19Speaker 2: It kind of all goes to waste. Versus if you
- 12:22Speaker 2: you've got a brilliant mind and a brilliant brain, you
- 12:25Speaker 2: can function there usually we can.
- 12:28Speaker 1: We can work on the other areas as well.
- 12:30Speaker 2: Obviously you've got to have a good healthy heart, good
- 12:33Speaker 2: good muscle. You know, there's there's all these other components.
- 12:38Speaker 2: But man, the brain is critical for long term longevity,
- 12:42Speaker 2: and so really interested in uh, these scientists are exploring
- 12:48Speaker 2: how these cells interact with nerve tissues and looking at
- 12:53Speaker 2: brain recovery on you know, with these muse cells, and
- 12:59Speaker 2: so you're seeing different studies in these models on how
- 13:06Speaker 2: it can affect with strokes, brain injuries like TBIs, nervous
- 13:11Speaker 2: system damage, neurodegenerative conditions like MS Parkinson's, those neurodegenerative conditions
- 13:20Speaker 2: that can be devastating.
- 13:23Speaker 1: And so if you know these muse.
- 13:26Speaker 2: Cells have you know, the researchers are thinking, hey, these
- 13:30Speaker 2: may have the potential to reverse some of these conditions.
- 13:36Speaker 2: We've seen it clinically be extremely helpful and a lot
- 13:41Speaker 2: of different conditions. But I wouldn't necessarily say like, hey,
- 13:45Speaker 2: this is the you know, panacea of the cure. But
- 13:51Speaker 2: what it does is it can go in and help
- 13:54Speaker 2: with repairing some of the damage, reduce some of that
- 13:57Speaker 2: inflammation that that fire in the brain and that gives
- 14:02Speaker 2: the ability to get back to some somewhat of a
- 14:07Speaker 2: normal function, you know. And then the other piece, so
- 14:12Speaker 2: talked about the brain, what about the heart and cardiovascular
- 14:17Speaker 2: research and so seeing some some very interesting things there
- 14:25Speaker 2: because you know, just like the brain, the heart muscle
- 14:28Speaker 2: and heart tissue once it's damaged, it's very difficult to
- 14:33Speaker 2: recover and repair heart tissue.
- 14:37Speaker 1: And so you know, these researchers are.
- 14:40Speaker 2: Exploring how MEW cells behaving cardiovascular environments and whether they
- 14:45Speaker 2: can mitigate towards injured tissues. So they're they're researching and
- 14:52Speaker 2: looking at how that tissue signaling is it's happening the inflammation,
- 14:59Speaker 2: right elation, what kind of cellular integration, meaning how those
- 15:04Speaker 2: cells come in and actually can turn and turn on
- 15:11Speaker 2: and regenerate heart cells, and then what are the recovery
- 15:15Speaker 2: support mechanisms. So very very interesting on mute cells with
- 15:22Speaker 2: the heart, and another very widely seen UH condition would
- 15:31Speaker 2: be in autoimmunity and in different inflammatory conditions. That's this
- 15:36Speaker 2: is where.
- 15:38Speaker 1: We're getting more and more.
- 15:41Speaker 2: You know, understanding of immune communication. But the interesting thing
- 15:48Speaker 2: with mute cells and being able to handle these inflammatory
- 15:52Speaker 2: environments and having high tolerance and what they're able to
- 15:59Speaker 2: to do to help help with with kind of clearing
- 16:03Speaker 2: up uh, immune compromised individuals. So, you know, if the
- 16:10Speaker 2: immune systems just that immune intelligence is reduced, maybe is
- 16:19Speaker 2: there's some ways that these stem cells can improve intelligence.
- 16:24Speaker 1: They're studying.
- 16:26Speaker 2: Autoimmune and inflammatory conditions, interested in how these cells interact
- 16:32Speaker 2: with immune signaling pathways. Doesn't necessarily mean that immune cells
- 16:38Speaker 2: or the solution to autoimmune conditions or diseases, but you know,
- 16:44Speaker 2: they're they're looking at some really important questions of how
- 16:47Speaker 2: do these cells communicate with with immune cells, why do
- 16:52Speaker 2: they appear to tolerate you certain environments, and what can
- 16:58Speaker 2: they teach us about inflammatory recovery and then just understanding
- 17:04Speaker 2: the overall immune communication. If if we can get that
- 17:08Speaker 2: information better, we're gonna These researchers believe they they have
- 17:15Speaker 2: more and more data and so, you know, from a
- 17:18Speaker 2: clinical standpoint, we've we've seen, you know, there's a few
- 17:24Speaker 2: things that we can measure when we've used these cells
- 17:30Speaker 2: with these treatments with someone with say an autoimmune condition
- 17:34Speaker 2: or or different things. Is we've we've had clients with
- 17:39Speaker 2: autoimmunity or our thyroid antibodies. We've we've seen homo systeine
- 17:45Speaker 2: levels elevated or a lot of inflammatory UH markers elevated,
- 17:51Speaker 2: and we're seeing, you know, from a clinical standpoint, and
- 17:55Speaker 2: I'm you know, you could say it's a correlation rather
- 18:00Speaker 2: than causation, because right now I'm on a recording published
- 18:04Speaker 2: on YouTube, and I don't necessarily want to say there's
- 18:06Speaker 2: there's any any specific condition or disease that we're treating.
- 18:10Speaker 2: But if you look at the measure of the results,
- 18:14Speaker 2: it's pretty intriguing and telling. When you see antibodies reduced,
- 18:19Speaker 2: when you see you know, inflammatory markers chains and shift,
- 18:25Speaker 2: I'm pretty pretty telling and exciting to see that. You know,
- 18:29Speaker 2: we're heading in the right direction. We have just some
- 18:32Speaker 2: some fascinating solutions here or potential solutions. So some of
- 18:38Speaker 2: the clinical trials I'm happening here, there's UH human clinical
- 18:44Speaker 2: research involving new cells. More and more we're seeing if
- 18:50Speaker 2: you look at a PubMed or I just met with
- 18:53Speaker 2: a new research group today that will help validate.
- 18:58Speaker 1: Certain research studies.
- 18:59Speaker 2: So I I'm excited to use some of that research
- 19:02Speaker 2: for our future Ageless Future podcasts.
- 19:06Speaker 1: But and the the data that we're seeing in.
- 19:11Speaker 2: Stem cells and specifically I muse cells. Just fascinating to
- 19:17Speaker 2: see all the more and more data coming out on
- 19:22Speaker 2: how how we can have better safety profiles. You know,
- 19:27Speaker 2: how how this tissue targetings work, different immune reactions, recovery outcomes,
- 19:33Speaker 2: and so you have you know, scientists in the lab
- 19:36Speaker 2: working and seeing how things interact in a laboratory setting.
- 19:43Speaker 2: You also will see it in isom rats. And now
- 19:47Speaker 2: we're starting to see some some unique different you know,
- 19:51Speaker 2: human human studies. For us at the clinical place, we're
- 19:58Speaker 2: not necessarily treating speci of diseases or conditions, so we
- 20:01Speaker 2: wouldn't qualify as you know, clinical trial. But you know
- 20:06Speaker 2: we're we're working potentially working with some groups to join there.
- 20:11Speaker 2: But overall from a longevity and health resilience standpoint, like
- 20:16Speaker 2: the downsides haven't found many or any, but and the
- 20:24Speaker 2: upside and potential significant, significant possibilities. And you know that
- 20:32Speaker 2: that leads us into what what this could mean for
- 20:34Speaker 2: longevity science because you know, we're we're looking at how
- 20:42Speaker 2: how can we preserve function and recovering, resilience and adapting
- 20:49Speaker 2: to changes, especially like talking about the brain, the heart,
- 20:54Speaker 2: the muscles, how those age can really.
- 20:57Speaker 1: Impact how how you know you you how.
- 21:01Speaker 2: Your longevity expectations are, and so some very very exciting
- 21:08Speaker 2: things there. And then you look at the future personalized
- 21:10Speaker 2: regenerative medicine and how reviewing some of these biomarkers and
- 21:15Speaker 2: advanced testing can really help shape the direction and the
- 21:20Speaker 2: right protocol and process. And essentially that's that's why we
- 21:25Speaker 2: applied for our patent on our our Ageless Future operating system.
- 21:31Speaker 1: Is you know, you think about if we can.
- 21:36Speaker 2: Get all the right tools and ingredients for someone's future
- 21:42Speaker 2: and then roadmap that out based on the right the
- 21:47Speaker 2: right diagnostics and then the right protocol, and then we
- 21:51Speaker 2: have the data that we're testing over and over and
- 21:56Speaker 2: seeing seeing amazing outcomes. And yeah, it's it's it's almost
- 22:02Speaker 2: like that that the future of personalized regenitive medicine is
- 22:07Speaker 2: here right now at Ageless Future. I think the rest
- 22:10Speaker 2: of medicine may you know, some some are catching up,
- 22:14Speaker 2: some are there, but man, we'd love being on the
- 22:17Speaker 2: forefront of that. And so, you know, if you look
- 22:20Speaker 2: at the bigger picture, are the vision the goal building
- 22:24Speaker 2: a resilient human system where you have longevity research, you know,
- 22:29Speaker 2: really focus on recovery and resilience. You have the cellular
- 22:32Speaker 2: repair systems that are becoming very very research heavy as well,
- 22:42Speaker 2: like recovering these I think I recorded a podcast a
- 22:46Speaker 2: couple of weeks ago with with a doctor that is
- 22:50Speaker 2: his his vision and his goal is no knee replacements
- 22:53Speaker 2: after I think it's twenty thirty two. I can't remember
- 22:58Speaker 2: the exact date. You guys are going to fact check
- 23:01Speaker 2: me on that, and I'm going.
- 23:01Speaker 1: To get it wrong.
- 23:02Speaker 2: But the point being is we have the regenerative medicine features.
- 23:09Speaker 2: We also have the lifestyle interventions and different peptides to
- 23:13Speaker 2: help eliminate unnecessary surgeries or these these barbaric surgeries where
- 23:21Speaker 2: you can have more regeneration and recovery. Obviously, there's always
- 23:25Speaker 2: going to be need for surgeries, and if there's a big.
- 23:30Speaker 1: Accidents, that can happen.
- 23:32Speaker 2: But if we can have ways to reduce how our
- 23:38Speaker 2: bodies break down and you know, knee replacements from arthritis,
- 23:43Speaker 2: arthritis is something that we should be able to hedge
- 23:46Speaker 2: because if we can get ahead of that and someone's
- 23:48Speaker 2: you know, twenties and thirties and have them recovering faster
- 23:52Speaker 2: and better and enhancing their resilience, arthritis will take a
- 23:57Speaker 2: lot longer time to form and maybe potentially we we
- 24:00Speaker 2: reduce or eliminate that completely. And that's that's obviously a
- 24:04Speaker 2: vision and a concept, but you know that that's one
- 24:08Speaker 2: of his uh doctor p Is vision. So yeah, the
- 24:13Speaker 2: future is really emphasizing on maintaining function rather than reacting
- 24:19Speaker 2: to decline, and not not even maintaining but enhancing and
- 24:24Speaker 2: continually improving and moving forward. And I think that's that's
- 24:28Speaker 2: what our stance at Ageless Future is is if you
- 24:32Speaker 2: always have a bigger future, you're always looking at that
- 24:36Speaker 2: like what's what's next from a health perspective, and you're
- 24:40Speaker 2: always growing there. Man, the sky's the limit. It's it's
- 24:45Speaker 2: when we kind of sit back and let a disease
- 24:48Speaker 2: or a diagnosis put a label on us and and
- 24:53Speaker 2: use that as you know, what what as an identity
- 24:58Speaker 2: and and those things are or what we've seen historically
- 25:02Speaker 2: really create you know, a downward spiral. And so if
- 25:06Speaker 2: we keep moving, we keep measuring and watching and always progressing,
- 25:13Speaker 2: it's really exciting and intriguing to see where things will
- 25:17Speaker 2: go from there.
- 25:18Speaker 1: And so.
- 25:20Speaker 2: Yeah, I want to issue guys a challenge this week,
- 25:24Speaker 2: so prioritize your sleep, movement, and recovery every day so
- 25:30Speaker 2: you can use this. So if you kind of follow
- 25:35Speaker 2: our six essentials, let's let's just start with sleep, so
- 25:40Speaker 2: we can get eight hours of sleep daily and then movement.
- 25:45Speaker 2: Thirty thirty is kind of the general rules, So thirty
- 25:48Speaker 2: minutes of like high intensity exercise, thirty minutes of outdoor
- 25:53Speaker 2: activity or exercise, So go mountain bike and go for
- 25:56Speaker 2: a walk or a run, or pickleball or skiing, whatever
- 26:02Speaker 2: it is. Get outside, get in the air, get at
- 26:05Speaker 2: least thirty minutes there, thirty minutes exercise hour total, get
- 26:11Speaker 2: your sleep, and feel amazing. Do what you can. You
- 26:18Speaker 2: control what you can control. Can't control all the variables
- 26:22Speaker 2: coming at you. But if you can make some decisions
- 26:25Speaker 2: right now of how I'm going to sleep, how I'm
- 26:28Speaker 2: going to move, and then what I put into my body,
- 26:33Speaker 2: and you know, just eliminate anything that's processed or that's
- 26:38Speaker 2: going to diminish your health. So that's going to be
- 26:41Speaker 2: like your process, junk, lots of sugar, artificial anything.
- 26:48Speaker 1: Around those areas.
- 26:49Speaker 2: Kind of stay away from focus on real foods, real proteins,
- 26:55Speaker 2: real real things. You're going to be headed in the
- 27:00Speaker 2: right direction. So Hopefully you had a good time today.
- 27:04Speaker 2: Appreciate you guys by joining me, and you have an
- 27:09Speaker 2: amazing day.
- 27:10Speaker 1: And thank you Ken.
- 27:11Speaker 2: Loved this fantastic information and cheers to a bright and
- 27:16Speaker 2: vibrant future. Love you all have an amazing day. I'll
- 27:20Speaker 2: see you next week.